Bharat Parenterals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Bharat Parenterals Ltd · Outcome · 29 Oct 2026, 10:25 pm
Bharat Parenterals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 13,628 (+110.9% YoY | +45.4% QoQ) ■ EBITDA: 2,358 (+2762.5% YoY | +176.3% QoQ) ■ EBITDA Margin (%): 17.3 (+1603 bps YoY | +820 bps QoQ) ■ PAT: 942 (Loss to Profit YoY | +834.4% QoQ) ■ EPS (INR): 17.2 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. · 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. · 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. · 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. · 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. · 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. · 25 Oct 2026
- Revised Voting Result · 25 Oct 2026
- Approval of Preferential Issue by shareholders of the company through EGM held on October 23, 2026. · 24 Oct 2026
